Literature DB >> 12594582

Outcome of postoperative pneumonia in the Eole study.

Hervé Dupont1, Philippe Montravers, Rémy Gauzit, Benoît Veber, Jean-Louis Pouriat, Claude Martin.   

Abstract

OBJECTIVES: Prognosis factors of ventilator-associated pneumonia (VAP) have been largely investigated, while the data concerning postoperative pneumonia (POP) are scarce. The aim of this multicenter, prospective study was to evaluate the predictive factors of mortality due to POP and the impact of initial antibiotic therapy on outcome.
METHODS: Two hundred centers were included. Diagnosis of POP was assessed on clinical and laboratory criteria, chest X-ray changes and microbiological criteria, when possible. Outcomes of the patients were noted. An independent committee made a retrospective assessment of appropriateness of antimicrobial therapy.
RESULTS: The overall mortality among the 556 cases of POP was 23% (126 patients). Five parameters were independently associated with mortality: American Society of Anesthesiology (ASA) grade 3 or more ( p<0.001), age 64 years or more ( p<0.01), time to onset of pneumonia more than 3 days ( p<0.01), mottling ( p<0.05) and hypotension ( p<0.05). Among the 322 microbiologically confirmed cases of pneumonia, 92 received inappropriate antibiotic (AB) therapy (29%). No difference in mortality was observed between the patients receiving inappropriate and appropriate AB therapy (22.8 vs 16.9%). In this subgroup, three parameters remained independently associated with mortality: ASA grade 3 or higher ( p<0.001), time to onset of pneumonia more than 3 days ( p<0.05) and hypotension ( p<0.05). Inappropriate initial AB did not modify the model ( p=0.22).
CONCLUSIONS: Five independent predictive factors for mortality of POP were identified. Despite a trend toward decreased mortality with appropriate initial antimicrobial therapy, no difference was observed between the groups. Polymicrobial pneumonia or non-fermenting Gram-negative bacilli appeared to be a risk factor for inappropriate AB.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12594582     DOI: 10.1007/s00134-002-1603-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  49 in total

1.  Nosocomial pneumonia. A multivariate analysis of risk and prognosis.

Authors:  R Celis; A Torres; J M Gatell; M Almela; R Rodríguez-Roisin; A Agustí-Vidal
Journal:  Chest       Date:  1988-02       Impact factor: 9.410

2.  Early diagnosis of postoperative pneumonia following upper abdominal surgery. A study in patients without cardiopulmonary disorder at operation.

Authors:  T Ejlertsen; P H Nielsen; S Jepsen; A Olsen
Journal:  Acta Chir Scand       Date:  1989-02

3.  Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome.

Authors:  M Ruiz; A Torres; S Ewig; M A Marcos; A Alcón; R Lledó; M A Asenjo; A Maldonaldo
Journal:  Am J Respir Crit Care Med       Date:  2000-07       Impact factor: 21.405

4.  Retrospective analysis of risk factors and prognosis in non-ventilated patients with nosocomial pneumonia.

Authors:  J Gómez; A Esquinas; M D Agudo; J M Sánchez Nieto; M L Núñez; V Baños; M Canteras; M Valdes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

5.  Specificity of endotracheal aspiration, protected specimen brush, and bronchoalveolar lavage in mechanically ventilated patients.

Authors:  A Torres; A Martos; J Puig de la Bellacasa; M Ferrer; M el-Ebiary; J González; A Gené; R Rodríguez-Roisin
Journal:  Am Rev Respir Dis       Date:  1993-04

6.  Pulmonary fungal infection: emphasis on microbiological spectra, patient outcome, and prognostic factors.

Authors:  K Y Chen; S C Ko; P R Hsueh; K T Luh; P C Yang
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

7.  The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia.

Authors:  M H Kollef; S Ward
Journal:  Chest       Date:  1998-02       Impact factor: 9.410

8.  Nosocomial pneumonia on general medical and surgical wards in a tertiary-care hospital.

Authors:  C A Greenaway; J Embil; P H Orr; J McLeod; B Dyck; L E Nicolle
Journal:  Infect Control Hosp Epidemiol       Date:  1997-11       Impact factor: 3.254

9.  Multivariate analysis of risk factors for postoperative pneumonia.

Authors:  T Fujita; K Sakurai
Journal:  Am J Surg       Date:  1995-03       Impact factor: 2.565

10.  Use of a bronchoscopic protected catheter brush for the diagnosis of pulmonary infections.

Authors:  N W Wimberley; J B Bass; B W Boyd; M B Kirkpatrick; R A Serio; H M Pollock
Journal:  Chest       Date:  1982-05       Impact factor: 9.410

View more
  15 in total

Review 1.  Year in review in Intensive Care Medicine-2003. Part 1: Respiratory failure, infection and sepsis.

Authors:  Edward Abraham; Peter Andrews; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Michael Pinsky; Peter Radermacher; Marco Ranieri; Christian Richard; Robert Tasker; Benoît Vallet
Journal:  Intensive Care Med       Date:  2004-05-15       Impact factor: 17.440

Review 2.  Excessive antimicrobial usage causes measurable harm to patients with suspected ventilator-associated pneumonia.

Authors:  Victor L Yu; Nina Singh
Journal:  Intensive Care Med       Date:  2004-02-28       Impact factor: 17.440

Review 3.  Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis.

Authors:  Mical Paul; Vered Shani; Eli Muchtar; Galia Kariv; Eyal Robenshtok; Leonard Leibovici
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

4.  Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures.

Authors:  Pieter Depuydt; Dominique Benoit; Dirk Vogelaers; Geert Claeys; Gerda Verschraegen; Koenraad Vandewoude; Johan Decruyenaere; Stijn Blot
Journal:  Intensive Care Med       Date:  2006-09-16       Impact factor: 17.440

5.  Impact of appropriateness of initial antibiotic therapy on outcome of postoperative pneumonia.

Authors:  Tetsuji Fujita; Yuichi Ishida; Katsuhiko Yanaga
Journal:  Langenbecks Arch Surg       Date:  2008-01-05       Impact factor: 3.445

6.  Defining, treating and preventing hospital acquired pneumonia: European perspective.

Authors:  Antoni Torres; Santiago Ewig; Harmut Lode; Jean Carlet
Journal:  Intensive Care Med       Date:  2008-11-07       Impact factor: 17.440

7.  Are preoperative oral care bundles needed to prevent postoperative pneumonia?

Authors:  Ignacio Martin-Loeches; Antoni Torres
Journal:  Intensive Care Med       Date:  2013-08-28       Impact factor: 17.440

8.  Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings.

Authors:  José Garnacho-Montero; C Ortiz-Leyba; Esteban Fernández-Hinojosa; Teresa Aldabó-Pallás; Aurelio Cayuela; Juan A Marquez-Vácaro; Andrés Garcia-Curiel; F J Jiménez-Jiménez
Journal:  Intensive Care Med       Date:  2005-03-23       Impact factor: 17.440

9.  Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality.

Authors:  C Peña; S Gómez-Zorrilla; I Oriol; F Tubau; M A Dominguez; M Pujol; J Ariza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-24       Impact factor: 3.267

Review 10.  An Argument for the Use of Aminoglycosides in the Empiric Treatment of Ventilator-Associated Pneumonia.

Authors:  Addison K May
Journal:  Surg Infect (Larchmt)       Date:  2016-04-01       Impact factor: 2.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.